MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.

MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.
复制标题

MiR-26a 通过抑制 MCL-1 抑制乳腺癌的增殖和迁移。

DOI:
10.1371/journal.pone.0065138
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Xie X
Xie X
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Gao J;Li L;Wu M;Liu M;Xie X;Guo J;Tang H;Xie X

文献摘要

参考文献

被引文献

相似文献

乳腺癌是女性中最常见的恶性肿瘤。MicroRNAs是一类长度为18-25个核苷酸的非编码小rna,可在转录后调节基因表达。MiR-26a已被报道为乳腺癌中的肿瘤抑制microRNA,其主要作用是靶向MTDH和EZH2,然而,MiR-26a的表达谱和治疗潜力尚不清楚。本研究证明miR-26a在乳腺癌细胞和临床标本中下调,其在乳腺癌细胞中的调节调节细胞增殖、集落形成、迁移和凋亡。MCL-1是Bcl-2家族的抗凋亡成员,作为miR-26a的新靶点,被发现与miR-26a的异位表达呈负相关,MCL-1的下调可表型化miR-26a在乳腺癌细胞系中的作用。进一步探讨miR-26a增加乳腺癌细胞对MCL-1参与的紫杉醇的敏感性。因此,miR-26a通过调节几种与癌变相关的过程,包括一种涉及靶向MCL-1的新机制,影响乳腺癌的细胞增殖和迁移。
Breast cancer is the most commonly malignancies in women. MicroRNAs are a family of small non-coding RNAs 18–25 nucleotides in length that post-transcriptionally modulate gene expression. MiR-26a has been reported as a tumor suppressor microRNA in breast cancer, which is attributed mainly to targeting of MTDH and EZH2, however, the expression profile and therapeutic potential of miR-26a is still unclear. Here we demonstrate that miR-26a is down-regulated in breast cancer cells and clinical specimens and its modulation in breast cancer cells regulates cell proliferation, colony formation, migration and apoptosis. MCL-1, an anti-apoptotic member of the Bcl-2 family, as novel targets of miR-26a was found to be in reverse correlation with ectopic expression of miR-26a and knockdown of MCL-1 phenocopied the effect of miR-26a in breast cancer cell lines. It was further explored that miR-26a increased sensitivity of breast cancer cells to paclitaxel in which MCL-1 was involved. Thus, miR-26a impacts on cell proliferation and migration of breast cancer by regulating several carcinogenesis-related processes, including a novel mechanism involving the targeting of MCL-1.
DOI: 10.1038/nature03702
发表时间: 2005-06-09
期刊: NATURE
影响因子: 64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者: Golub, TR
DOI: 10.1016/s1470-2045(04)01431-7
发表时间: 2004-04-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Entschladen, F;Drell, TL;Zaenker, KS
通讯作者: Zaenker, KS
DOI: 10.1158/0008-5472.can-05-1783
发表时间: 2005-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Iorio, MV;Ferracin, M;Croce, CM
通讯作者: Croce, CM
DOI: 10.1056/nejmoa0901282
发表时间: 2009-10-08
期刊: The New England journal of medicine
影响因子: --
作者:
Ji J;Shi J;Budhu A;Yu Z;Forgues M;Roessler S;Ambs S;Chen Y;Meltzer PS;Croce CM;Qin LX;Man K;Lo CM;Lee J;Ng IO;Fan J;Tang ZY;Sun HC;Wang XW
通讯作者: Wang XW
DOI: 10.1101/gad.1777409
发表时间: 2009-06-01
影响因子: 10.5
作者:
Huse, Jason T.;Brennan, Cameron;Holland, Eric C.
通讯作者: Holland, Eric C.